Winton Group LTD Biomarin Pharmaceutical Inc Transaction History

Winton Group LTD

$2.35 Billion
Q3 2025

A detailed history of Winton Group LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Winton Group LTD holds 123,474 shares of BMRN stock, worth $6.69 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

123,474

Previous 4,207 2834.97%

Holding current value

$6.69 Million

Previous $231,000 2794.81%

% of portfolio

0.28%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$52.62 - $61.93 $6.28 Million - $7.39 Million	119,267 Added 2834.97%	123,474 $6.69 Million
Q2 2025 Aug 14, 2025	SELL	$54.08 - $68.32 $688,654 - $869,986	-12,734 Reduced 75.17%	4,207 $231,000
Q1 2025 May 15, 2025	BUY	$61.25 - $72.83 $16,353 - $19,445	267 Added 1.6%	16,941 $1.2 Million
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $287,293 - $327,003	-4,639 Reduced 21.77%	16,674 $1.1 Million
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $1.04 Million - $1.42 Million	15,125 Added 244.42%	21,313 $1.5 Million
Q2 2024 Aug 09, 2024	BUY	$74.43 - $92.22 $460,572 - $570,657	6,188 New	6,188 $509,000
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $1.4 Million - $1.56 Million	16,494 Added 391.04%	20,712 $1.83 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $1.45 Million - $1.68 Million	-16,749 Reduced 79.88%	4,218 $365,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $141,436 - $189,039	1,612 Added 8.33%	20,967 $2.04 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $606,489 - $814,073	-7,494 Reduced 27.91%	19,355 $2 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $698,688 - $824,377	-8,504 Reduced 24.05%	26,849 $2.28 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $1.69 Million - $2.05 Million	23,649 Added 202.06%	35,353 $2.93 Million
Q1 2022 May 11, 2022	BUY	$74.28 - $92.69 $160,741 - $200,581	2,164 Added 22.68%	11,704 $902,000
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $610,695 - $778,867	-8,515 Reduced 47.16%	9,540 $843,000
Q3 2021 Oct 28, 2021	BUY	$74.77 - $85.47 $455,947 - $521,196	6,098 Added 51.0%	18,055 $1.4 Million
Q2 2021 Aug 10, 2021	BUY	$75.51 - $84.79 $48,099 - $54,011	637 Added 5.63%	11,957 $998,000
Q1 2021 Jul 21, 2021	BUY	$74.73 - $90.69 $233,157 - $282,952	3,120 Added 38.05%	11,320 $855,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $1.78 Million - $2.22 Million	-24,574 Reduced 74.98%	8,200 $719,000
Q3 2020 Oct 30, 2020	SELL	$71.87 - $131.03 $1.65 Million - $3.01 Million	-22,949 Reduced 41.18%	32,774 $2.49 Million
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $2.02 Million - $3.16 Million	25,453 Added 84.09%	55,723 $6.87 Million
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $2.16 Million - $2.93 Million	30,270 New	30,270 $2.56 Million
Q4 2017 Feb 13, 2018	SELL	$80.76 - $95.13 $7.24 Million - $8.53 Million	-89,673 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $7.03 Million - $8.28 Million	87,223 Added 3560.12%	89,673 $8.35 Million
Q2 2017 Aug 17, 2017	BUY	N/A	2,450	2,450 $223,000

Others Institutions Holding BMRN

# of Institutions

683

Shares Held

189M

Call Options Held

1.31M

Put Options Held

1.09M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account